These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22560500)

  • 1. From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease.
    Bellucci A; Zaltieri M; Navarria L; Grigoletto J; Missale C; Spano P
    Brain Res; 2012 Oct; 1476():183-202. PubMed ID: 22560500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.
    Bellucci A; Navarria L; Zaltieri M; Missale C; Spano P
    Brain Res; 2012 Jan; 1432():95-113. PubMed ID: 22153624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Contribution of
    Longhena F; Faustini G; Missale C; Pizzi M; Spano P; Bellucci A
    Neural Plast; 2017; 2017():5012129. PubMed ID: 28133550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic failure and α-synuclein.
    Calo L; Wegrzynowicz M; Santivañez-Perez J; Grazia Spillantini M
    Mov Disord; 2016 Feb; 31(2):169-77. PubMed ID: 26790375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
    Li B; Zhang Y; Yuan Y; Chen N
    Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-dependent secretion of alpha-synuclein by enteric neurons.
    Paillusson S; Clairembault T; Biraud M; Neunlist M; Derkinderen P
    J Neurochem; 2013 May; 125(4):512-7. PubMed ID: 23278133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of α-synuclein in neurodegeneration: implications for the pathogenesis of Parkinson's disease.
    Yu S; Chan P
    Essays Biochem; 2014; 56():125-35. PubMed ID: 25131591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
    Sidhu A; Wersinger C; Vernier P
    FASEB J; 2004 Apr; 18(6):637-47. PubMed ID: 15054086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
    Braak H; de Vos RA; Bohl J; Del Tredici K
    Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain.
    Totterdell S; Meredith GE
    Neuroscience; 2005; 135(3):907-13. PubMed ID: 16112475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease.
    Chu Y; Mickiewicz AL; Kordower JH
    Neurobiol Dis; 2011 Jan; 41(1):71-82. PubMed ID: 20816781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M; Lopiano L
    Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
    Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH
    Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.